Cargando…
The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is associated with gut dysbiosis, enhanced gut permeability, adiposity and insulin resistance. Prebiotics such as human milk oligosaccharide 2′-fucosyllactose are thought to primarily improve gut health and it is unc...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248376/ https://www.ncbi.nlm.nih.gov/pubmed/35782914 http://dx.doi.org/10.3389/fnut.2022.904740 |
_version_ | 1784739353892749312 |
---|---|
author | Gart, Eveline Salic, Kanita Morrison, Martine C. Giera, Martin Attema, Joline de Ruiter, Christa Caspers, Martien Schuren, Frank Bobeldijk-Pastorova, Ivana Heer, Marianne Qin, Yan Kleemann, Robert |
author_facet | Gart, Eveline Salic, Kanita Morrison, Martine C. Giera, Martin Attema, Joline de Ruiter, Christa Caspers, Martien Schuren, Frank Bobeldijk-Pastorova, Ivana Heer, Marianne Qin, Yan Kleemann, Robert |
author_sort | Gart, Eveline |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is associated with gut dysbiosis, enhanced gut permeability, adiposity and insulin resistance. Prebiotics such as human milk oligosaccharide 2′-fucosyllactose are thought to primarily improve gut health and it is uncertain whether they would affect more distant organs. This study investigates whether 2′-fucosyllactose can alleviate NAFLD development in manifest obesity. Obese hyperinsulinemic Ldlr-/-.Leiden mice, after an 8 week run-in on a high-fat diet (HFD), were treated with 2′-fucosyllactose by oral gavage until week 28 and compared to HFD-vehicle controls. 2′-fucosyllactose did not affect food intake, body weight, total fat mass or plasma lipids. 2′-fucosyllactose altered the fecal microbiota composition which was paralleled by a suppression of HFD-induced gut permeability at t = 12 weeks. 2′-fucosyllactose significantly attenuated the development of NAFLD by reducing microvesicular steatosis. These hepatoprotective effects were supported by upstream regulator analyses showing that 2′-fucosyllactose activated ACOX1 (involved in lipid catabolism), while deactivating SREBF1 (involved in lipogenesis). Furthermore, 2′-fucosyllactose suppressed ATF4, ATF6, ERN1, and NUPR1 all of which participate in endoplasmic reticulum stress. 2′-fucosyllactose reduced fasting insulin concentrations and HOMA-IR, which was corroborated by decreased intrahepatic diacylglycerols. In conclusion, long-term supplementation with 2′-fucosyllactose can counteract the detrimental effects of HFD on gut dysbiosis and gut permeability and attenuates the development of liver steatosis. The observed reduction in intrahepatic diacylglycerols provides a mechanistic rationale for the improvement of hyperinsulinemia and supports the use of 2′-fucosyllactose to correct dysmetabolism and insulin resistance. |
format | Online Article Text |
id | pubmed-9248376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92483762022-07-02 The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice Gart, Eveline Salic, Kanita Morrison, Martine C. Giera, Martin Attema, Joline de Ruiter, Christa Caspers, Martien Schuren, Frank Bobeldijk-Pastorova, Ivana Heer, Marianne Qin, Yan Kleemann, Robert Front Nutr Nutrition Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is associated with gut dysbiosis, enhanced gut permeability, adiposity and insulin resistance. Prebiotics such as human milk oligosaccharide 2′-fucosyllactose are thought to primarily improve gut health and it is uncertain whether they would affect more distant organs. This study investigates whether 2′-fucosyllactose can alleviate NAFLD development in manifest obesity. Obese hyperinsulinemic Ldlr-/-.Leiden mice, after an 8 week run-in on a high-fat diet (HFD), were treated with 2′-fucosyllactose by oral gavage until week 28 and compared to HFD-vehicle controls. 2′-fucosyllactose did not affect food intake, body weight, total fat mass or plasma lipids. 2′-fucosyllactose altered the fecal microbiota composition which was paralleled by a suppression of HFD-induced gut permeability at t = 12 weeks. 2′-fucosyllactose significantly attenuated the development of NAFLD by reducing microvesicular steatosis. These hepatoprotective effects were supported by upstream regulator analyses showing that 2′-fucosyllactose activated ACOX1 (involved in lipid catabolism), while deactivating SREBF1 (involved in lipogenesis). Furthermore, 2′-fucosyllactose suppressed ATF4, ATF6, ERN1, and NUPR1 all of which participate in endoplasmic reticulum stress. 2′-fucosyllactose reduced fasting insulin concentrations and HOMA-IR, which was corroborated by decreased intrahepatic diacylglycerols. In conclusion, long-term supplementation with 2′-fucosyllactose can counteract the detrimental effects of HFD on gut dysbiosis and gut permeability and attenuates the development of liver steatosis. The observed reduction in intrahepatic diacylglycerols provides a mechanistic rationale for the improvement of hyperinsulinemia and supports the use of 2′-fucosyllactose to correct dysmetabolism and insulin resistance. Frontiers Media S.A. 2022-06-17 /pmc/articles/PMC9248376/ /pubmed/35782914 http://dx.doi.org/10.3389/fnut.2022.904740 Text en Copyright © 2022 Gart, Salic, Morrison, Giera, Attema, de Ruiter, Caspers, Schuren, Bobeldijk-Pastorova, Heer, Qin and Kleemann. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Gart, Eveline Salic, Kanita Morrison, Martine C. Giera, Martin Attema, Joline de Ruiter, Christa Caspers, Martien Schuren, Frank Bobeldijk-Pastorova, Ivana Heer, Marianne Qin, Yan Kleemann, Robert The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title | The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title_full | The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title_fullStr | The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title_full_unstemmed | The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title_short | The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice |
title_sort | human milk oligosaccharide 2′-fucosyllactose alleviates liver steatosis, er stress and insulin resistance by reducing hepatic diacylglycerols and improved gut permeability in obese ldlr-/-.leiden mice |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248376/ https://www.ncbi.nlm.nih.gov/pubmed/35782914 http://dx.doi.org/10.3389/fnut.2022.904740 |
work_keys_str_mv | AT garteveline thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT salickanita thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT morrisonmartinec thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT gieramartin thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT attemajoline thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT deruiterchrista thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT caspersmartien thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT schurenfrank thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT bobeldijkpastorovaivana thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT heermarianne thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT qinyan thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT kleemannrobert thehumanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT garteveline humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT salickanita humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT morrisonmartinec humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT gieramartin humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT attemajoline humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT deruiterchrista humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT caspersmartien humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT schurenfrank humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT bobeldijkpastorovaivana humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT heermarianne humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT qinyan humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice AT kleemannrobert humanmilkoligosaccharide2fucosyllactosealleviatesliversteatosiserstressandinsulinresistancebyreducinghepaticdiacylglycerolsandimprovedgutpermeabilityinobeseldlrleidenmice |